Risk of cardiovascular disease and loss in life expectancy in NAFLD-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Risk of cardiovascular disease and loss in life expectancy in NAFLD

Published:2022-04-23 Issue:5 Volume:76 Page:1495-1505
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Shang Ying¹^ORCID,Nasr Patrik¹²,Widman Linnea³,Hagström Hannes¹⁴⁵^ORCID

Affiliation:

1. Department of Medicine Huddinge Karolinska Institutet Stockholm Sweden

2. Department of Gastroenterology and Hepatology Department of Health, Medicine and Caring Sciences Linköping University Linköping Sweden

3. Division of Biostatistics Institute of Environmental Medicine Karolinska Institutet Stockholm Sweden

4. Division of Hepatology Department of Upper GI Karolinska University Hospital Stockholm Sweden

5. Clinical Epidemiology Unit Department of Medicine Karolinska Institutet Stockholm Sweden

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hep.32519

Reference33 articles.

1. Global Perspectives on Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis

2. The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: A systematic review and meta-analysis

3. The Metabolic Syndrome and Total and Cardiovascular Disease Mortality in Middle-aged Men

4. Liver Fat in the Metabolic Syndrome

5. Synergistic increase in cardiovascular risk in diabetes mellitus with nonalcoholic fatty liver disease

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural history and progression of metabolic dysfunction-associated steatotic liver disease;The Lancet Gastroenterology & Hepatology;2024-10

2. Emerging mechanisms of non-alcoholic steatohepatitis and novel drug therapies;Chinese Journal of Natural Medicines;2024-08

3. Pemafibrate abrogates SLD in a rat experimental dietary model, inducing a shift in fecal bile acids and microbiota composition;Biomedicine & Pharmacotherapy;2024-08

4. Treatment Options and Continuity of Care in Metabolic-associated Fatty Liver Disease: A Multidisciplinary Approach;European Cardiology Review;2024-06-19

5. The relationship between muscle mass and fat content in body composition and non-alcoholic fatty liver disease in the Chinese general population: a cross-sectional study;Frontiers in Medicine;2024-06-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3